Are Jeffries’ analysts ‘investors’ or ‘traders’?Taken from The Australian. So, watch out for an explosion in the CUV SP seeing as the downgrade to 'hold' from Jefferies was put forward at the catalyst for the sell off.
View attachment 2631
PW will have to open the purse on this one. As you would have seen in at least one report I posted here regarding strokes in Australia the number/frequency of strokes is enormous. But if Clinuvel restricts trial activities to 1/2 sites that's going to cause problems because even though Clinuvel espouses they could potentially treat 80% of strokes, they had a hard enough time treating 6 patients. At any rate such is the frequency of strokes in Melbourne and actually any major city worldwide that they have the opportunity to trial city wide and capture the required number of patients if they choose to in a reasonable timeframe (Covid considerations aside). Seriously hoping they conduct the Phase 3 trial across at least several centres otherwise it will be a long haul.c) Any phase 3 completion is only dependent on recruitment numbers which appears to be a consistent flow in 1 center in Australia, consider Germany's 1700 per week as an example of where a larger cohort could be performed